These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6405303)

  • 1. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury.
    Faden AI; Jacobs TP; Smith MT; Holaday JW
    Neurology; 1983 Jun; 33(6):673-8. PubMed ID: 6405303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone.
    Arias MJ
    Surg Neurol; 1987 Nov; 28(5):335-8. PubMed ID: 3116691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of experimental spinal cord trauma. Comparison of treatment with TRH, naloxone, and dexamethasone.
    Akdemir H; Paşaoğlu A; Oztürk F; Selçuklu A; Koç K; Kurtsoy A
    Res Exp Med (Berl); 1992; 192(3):177-83. PubMed ID: 1636062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats.
    Faden AI; Jacobs TP; Holaday JW
    N Engl J Med; 1981 Oct; 305(18):1063-7. PubMed ID: 6792542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of acute spinal cord injuries.
    Ceylan S; Kalelioğlu M; Aktürk G; Aktürk F; Ceylan S
    Res Exp Med (Berl); 1990; 190(2):111-9. PubMed ID: 2112263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment.
    Faden AI; Jacobs TP; Smith MT
    Neurology; 1984 Oct; 34(10):1280-4. PubMed ID: 6435011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking weight-induced spinal cord injury in rats: effects of TRH or naloxone on motor function recovery and spinal cord blood flow.
    Holtz A; Nyström B; Gerdin B
    Acta Neurol Scand; 1989 Sep; 80(3):215-20. PubMed ID: 2508415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyrotropin-releasing hormone on the neurologic impairment in rats with spinal cord injury: treatment starting 24 h and 7 days after injury.
    Hashimoto T; Fukuda N
    Eur J Pharmacol; 1991 Oct; 203(1):25-32. PubMed ID: 1797554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate antagonist in traumatic shock.
    McIntosh TK; Faden AI
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early and late naloxone treatment in experimental spinal injury.
    Faden AI; Jacobs TP; Holaday JW
    Neurology; 1982 Jun; 32(6):677-81. PubMed ID: 7201101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TRH analogs on neurologic recovery after experimental spinal trauma.
    Faden AI; Jacobs TP
    Neurology; 1985 Sep; 35(9):1331-4. PubMed ID: 3927187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.
    McIntosh TK; Fernyak S; Hayes RL; Faden AI
    J Neurotrauma; 1993; 10(4):373-84. PubMed ID: 8145261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke".
    Holaday JW; D'Amato RJ
    Life Sci; 1982 Jul; 31(4):385-92. PubMed ID: 6815400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat.
    Obana WG; Pitts LH; Nishimura MC
    J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thyrotropin-releasing hormone on acute experimental traumatic head injury in cats.
    Wang GL; Zhu C
    Chin Med J (Engl); 1991 Nov; 104(11):939-44. PubMed ID: 1800036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of TRH analogs in rat spinal cord injury.
    Faden AI; Sacksen I; Noble LJ
    Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.